logo
Book a meeting
REGENXBIO

Regenxbio

Biotechnology, 9804 Medical Center Dr, Rockville, Maryland, 20850, United States, 201-500 Employees

regenxbio.com

  • twitter
  • LinkedIn

phone no Phone Number: 24********

Who is REGENXBIO

REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technolog...

Read More

lock icon Get Full Access
map
  • 9804 Medical Center Dr, Rockville, Maryland, 20850, United States Headquarters: 9804 Medical Center Dr, Rockville, Maryland, 20850, United States
  • 2008 Date Founded: 2008
  • 201-500 Employees: 201-500
  • dollar-icon Revenue: $250 Million to $500 Million
  • tech-icon Active Tech Stack: See technologies
  • Lisa Reid CEO:   Lisa Reid

industries-icon Industry: Biotechnology

SIC SIC Code: 2836 | NAICS Code: 541714 | Show More

checked-icon Does something look wrong? Fix it. | View contact records from REGENXBIO

REGENXBIO Org Chart and Mapping

Lisa Reid

Lisa Reid

Executive Assistant to Chief Executive Officer

Employees
Henos Negash

Henos Negash

Immunology Lab Technician

Yanhong Wei

Yanhong Wei

Project Manager

Diane Doughty

Diane Doughty

Director, Device Development

Hayley Carroll

Hayley Carroll

Associate Scientist I

Andrew Mercer

Andrew Mercer

Director, Gene Therapy Research

Mary Dimarco

Mary Dimarco

Director, Regulatory Operations

Christina Vardavas

Christina Vardavas

Supply Chain Associate

Isaac McCabe

Isaac McCabe

Human Resources Summer Intern

Justin Glenn

Justin Glenn

Senior Scientist

See Full Org Chart arrow
email-formate-icon
View Email Formats for REGENXBIO
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding REGENXBIO

Answer: REGENXBIO's headquarters are located at 9804 Medical Center Dr, Rockville, Maryland, 20850, United States

Answer: REGENXBIO's phone number is 24********

Answer: REGENXBIO's official website is https://regenxbio.com

Answer: REGENXBIO's revenue is $250 Million to $500 Million

Answer: REGENXBIO's SIC: 2836

Answer: REGENXBIO's NAICS: 541714

Answer: REGENXBIO has 201-500 employees

Answer: REGENXBIO is in Biotechnology

Answer: REGENXBIO contact info: Phone number: 24******** Website: https://regenxbio.com

Answer: REGENXBIO is a leading biotechnology company focused on the development, commercialization and licensing of recombinant adenoassociated virus (AAV) gene therapy. REGENXBIO's NAV Technology Platform, a proprietary AAV gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO's mission is to transform the lives of patients suffering from severe diseases with significant unmet medical need by developing and commercializing in vivo gene therapy products based on REGENXBIO's NAV Technology Platform. REGENXBIO seeks to accomplish this mission through a combination of internal development efforts and thirdparty NAV Technology Platform licensees.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access